GOCO logo

GoHealth, Inc. Class A Common Stock

GOCONASDAQ
US Equity
$93.72β–Ό $3.66 (βˆ’3.91%)
Simulated price
1hβ€”
24hβ–Ό 3.9%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$230B
Large Cap
πŸ“ˆRevenue Growth (YoY)
+14.5%
Healthy
πŸ“ŠGross Margin
75.5%
High
πŸ’΅FCF Margin
8.2%
Moderate
βš–οΈP/S Ratio
14.6x
Expensive
Otter Score
47
Weak
No chart data available for GOCO.

Trading Snapshot

Day Range
$92.32 – $94.38
52-Week Range
$40.91 – $144.42
Volume
$2.77B
Avg Volume
$2.22B
Shares Outstanding
2.46B
Next Earnings
Oct 1, 2026

Fundamentals Snapshot

Annual Revenue
$15.79B
Last Q Revenue
$3.76B
P/E Ratio
30.1
P/S Ratio
14.6x
EPS (TTM)
$3.11
Dividend Yield
3.92%

Why Investors Own GOCO

  • βœ“High-growth profile β€” revenue up +14.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 76% gross margin and 8% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$15.79Bβ–² +19.0% YoY
Gross Margin (TTM)
75.5%β–² +0.2% YoY
Operating Income (TTM)
$4.12Bβ–² +19.0% YoY
Free Cash Flow (TTM)
$1.29Bβ–² +19.0% YoY

About GoHealth, Inc. Class A Common Stock

A company profile for GoHealth, Inc. Class A Common Stock isn’t available yet β€” check back soon.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
47/100

Analyst Price Target

β“˜
Average Target
$108.37
β–² +15.6% Upside
High Target$120.80
Low Target$82.61
Based on 28 analysts

Latest News & Updates